KCT0000453
Completed
未知
Evaluation of clinical efficacy of autologous plasma therapy for the patients with recalcitrant atopic dermatitis and identification of plasma fraction mediating therapeutic efficacy
Ajou University Hospital0 sites36 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
- Sponsor
- Ajou University Hospital
- Enrollment
- 36
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •36 patients with recalcitrant AD whose clinical conditions had not been effectively controlled by current standard medical therapies (topical moisturizers, topical corticosteroids, topical calcineurin inhibitors, and oral antihistamines) for more than 6 months who visited out\-patient clinic of the university hospital will be recruited. Written informed consent on this study will be received from all the participating patients and the patients will be divided into 2 experimental groups (12 patients in autologous plasma injection group, 12 patients in high molecular plasma protein injection group) and 1 control group (12 patients in saline injection group) for this study.
Exclusion Criteria
- •1\) Patients under the age of 16
- •2\) Patients who are unable to agree on their own (emergency patients, patients with mental disability, patients with limited capacity to consent due to stroke or delirium caused by diabetes)
- •3\) Pregnancy or planned pregnancy within 1 year
- •4\) Skin condition not appropriate for blood sampling and transfusion
- •5\) Patients with contraindication for blood transfusion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of male post prostatectomy urinary incontinencepost prostatectomy urinary incontinenceJPRN-jRCTc030230395Abe Hirokazu40
Recruiting
Not Applicable
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of female stress urinary incontinenceJPRN-jRCTc030230394Abe Hirokazu40
Not yet recruiting
Phase 3
Autologous platelet rich plasma in dry eye diseaseCTRI/2021/03/031887Department of ophthalmology
Recruiting
Not Applicable
Clinical Study of Safety and Efficacy of Autologous Mesenchymal Stem Cells for Periodontal Tissue Regeneration TherapyPeriodontal DiseaseJPRN-jRCTb070230008Cho Yasushi22
Active, not recruiting
Not Applicable
Effects of autologous (OWN) platelet-poor plasma on prevention of bronchopleural fistula and lung damage in patients undergoing lung resectioBronchopleural fistulaMedDRA version: 14.1Level: PTClassification code 10053481Term: Bronchopleural fistulaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2012-000397-30-ESFUNDACIÓN CANARIA DE INVESTIGACIÓN Y SALUD (FUNCIS)